Ault Milton C III's Form 4 filing
Alzamend Neuro, Inc. (ALZN) · filed Dec 20, 2022
- Accession no.
- 0001214659-22-015128
- Filed
- Dec 20, 2022
- Trade date
- Dec 16-19, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $36.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ault Milton C IIICIK 0001212502 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $0.90 | +$18,000 | 345,000 | Indirect | |
| Dec 19, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $0.82 | +$16,400 | 365,000 | Indirect | |
| Dec 19, 2022 | Common Stock | PPurchaseAcquired | +3,000 | $0.82F2 | +$2,460 | 11,041,001 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.8184. The range of purchase prices on the transaction date was $0.8154 to $0.8198 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 1 transaction in Table I.